U.S. Court of Appeals for the Fifth Circuit, 2026

Northside Pharmacy v. DEA

Northside Pharmacy v. DEA
U.S. Court of Appeals for the Fifth Circuit · Decided April 13, 2026
Northside Pharmacy v. DEA

Opinion

Case: 25-20200 Document: 49-1 Page: 1 Date Filed: 04/13/2026

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

____________ FILED April 13, 2026 No. 25-20200 Lyle W. Cayce ____________ Clerk Northside Pharmacy, L.L.C., A Texas limited liability company, Plaintiff—Appellant, versus Drug Enforcement Administration, A Federal administrative agency; Derek Maltz, Acting Director of the Drug Enforcement Administration, Defendants—Appellees. ______________________________ Appeal from the United States District Court for the Southern District of Texas USDC No. 4:24-CV-3951 ______________________________ Before Richman, Duncan, and Oldham, Circuit Judges.

Per Curiam: * Plaintiff Northside Pharmacy appeals the dismissal of its claim for declaratory and injunctive relief in connection with the Drug Enforcement Administration’s suspension of Northside’s Certification of Registration.

_____________________ * This opinion is not designated for publication. See 5th Cir. R. 47.5.

Case: 25-20200 Document: 49-1 Page: 2 Date Filed: 04/13/2026

No. 25-20200

Having reviewed the record, the district court order, and the parties’ briefing, we find no error. AFFIRMED.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.